Skip to main content
. 2018;19(3):661–665. doi: 10.22034/APJCP.2018.19.3.661

Table 3.

NKG2D Expressed on NK Cells and T Lymphocytes

Patients group Healthy controls P
NKG2D on NK cells (%) 95.45 (92.83) 96.10 (92.00) 0.877b
NKG2D on CD4+ T lymphocytes (%) 1.05 (0.50) 0.6 (0.4) 0.061b
NKG2D on CD8+ T lymphocytes (%)* 94.14 ± 2.90 96.05 ± 1.96 <0.001a
a

Student’s t-test;

b

Mann-Whitney U test;

*

P <0.05 indicates statistical significance between the two groups.